Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00068224 : Clinical and Molecular Investigations Into Ciliopathies
PhaseN/A
AgesMin: 6 Months Max: 80 Years
Eligibility
- INCLUSION CRITERIA:

This protocol will enroll children and adults who carry a clinical diagnosis of ARPKD,
CHF, JSRD, BBS, OFD or AS and who has either PKD/NP spectrum of changes in the kidneys or
CHF/Caroli s syndrome of the liver. This might rarely include adults who are unable to
give informed consent.

Among patients who have received a kidney or liver allograft, those with stable graft
function and without severe transplant-related complications are eligible for enrollment.
Patients and their parents/legal guardians must be willing to come to the NIH Clinical
Center for admission annually.

EXCLUSION CRITERIA:

Infants under 6 months of age.

Medically fragile patients who require frequent hospitalizations due to complications of
end-stage renal disease (uncontrolled hypertension, severe electrolyte imbalances) or
hepatic disease (current variceal bleeding, overt encephalopathy, intractable recurrent
cholangitis).
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00068224      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740